XEVMPD and Article 57
Explore all topics, guides, and frameworks related to XEVMPD and Article 57.
Articles in this section
4- Maintaining XEVMPD Through the Product Lifecycle: Variations, Transfers, Renewals, Suspensions and Withdrawals Article 57 data must track the changing regulatory state of a medicinal product. This article explains the full lifecycle event model, regulatory triggers, responsibilities, verification and governance. Read Article →
- XEVMPD Lifecycle Maintenance: Managing Variations, Transfers and Withdrawals This article focuses on how approved variations, transfers and withdrawals are translated into controlled XEVMPD maintenance, distinguishing the regulatory procedure from the downstream product-data transaction. Read Article →
- XEVMPD Data Quality: Common Errors, Validation and Maintenance XEVMPD data quality depends on more than successful submission. This article explains how MAHs maintain accurate, complete, current and traceable Article 57 medicinal-product data. Read Article →
- XEVMPD Data Quality: Reconciliation, Completeness and Detecting Hidden Errors Reconciliation tests whether XEVMPD reflects the expected medicinal-product portfolio and regulatory state. This article explains population definition, source hierarchy, discrepancy investigation, hidden errors and governance. Read Article →